🎗️ OncologyInjection (IV)
Lynozyfic
Linvoseltamab
BCMA-directed bispecific antibody for relapsed/refractory multiple myeloma after at least 4 prior lines of therapy.
Form
Injection (IV)
Uses
1
Side effects
5
Category
Oncology
01
What is Lynozyfic used for?
- Relapsed/refractory multiple myeloma
02
Linvoseltamab side effects
Common side effects of Linvoseltamab include:
Cytokine release syndrome
Infections
Neutropenia
Anemia
Neurotoxicity
CommonModerateLess common
03
Linvoseltamab warnings & precautions
- Black box: CRS and ICANS. Step-up dosing and REMS required
- Serious infections possible
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Lynozyfic in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.